Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
MedPlus Health Services informed the exchanges that its subsidiary Optival Health Solutions Private Limited received a one-day suspension order for the drug license of its store located at KC Rani Road, Gadag, Karnataka. The order was issued by the Assistant Director, Drugs Control Administration, Gadag Circle, on January 2, 2026, under Rule 65 of the Drugs and Cosmetics Act, 1940. The estimated financial impact is a potential revenue loss of approximately Rs. 0.23 lacs. The suspension applies to a single store and is limited in duration.
The financial impact is negligible at around Rs. 0.23 lacs, and the suspension is limited to one store for a single day, so it is unlikely to materially affect operations, earnings, or the stock price.